Dr. Ashwani Sharma is currently CEO of Insight Biosolutions, France and MD of Moldoc Biotech Private Limited, India. Dr. Ashwani SHARMA has more than 15 years’ of working experience in the fields of computational chemistry and biology for solving biotech industries’ problems. After a Ph.D. in Bioinformatics, he worked with European companies for safety assessment of pharma and cosmetic products using molecular modeling and machine learning techniques along with the commercialization of technology. As a member of the board and President of the scientific committee of the French society “Group of metabolism and Pharmacokinetics” GMP and European Society for Alternatives to Animal Testing (EUSAAT), Dr Ashwani provides support for using in-vitro/in-silico models for safety assessment of pharma and cosmetic products.
Dr. Ahmet Katı is an academician and Bioentrepreneur for animal free test solutions. He is currently working at University of Health Sciences. He established the Omic-A Research and Innovation biotech startup which is dedicated for alternatives to animal testing.
Dr. Pakize Neslihan Taşlı completed her undergraduate studies at Haliç University, and her graduate studies at Yeditepe University. After completing her PhD on the in vitro production of teeth using a combination of different mesenchymal stem cell lines, she continued her studies in the field of extracellular vesicles and mesenchymal stem cells. In 2016, she founded the “Extracellular Vesicles and Exosomes Research Group”. Her lab has published several research articles and were granted method and product patents in the field of extracellular vesicles research.
Emrah Eroglu, as a biotechnologist and molecular biologist he is fascinated by developing novel tools and techniques, which permits us to shed light on cells down to the level of single molecules. Together with their friends at the Medical University of Graz, the Harvard Medical School in Boston, King’s College London and Istanbul Medipol University He has developed a several novel tools and genetically encoded biosensors for real-time imaging of signaling molecules including Calcium, Nitric Oxide, ATP, Potassium, and Hydrogen peroxide. In August 2019 they established a new live-cell imaging laboratory at the Sabanci University. In August 2022 they moved their lab to Istanbul Medipol University to join forces with partner labs at SABITA which is a unique research facility and high-end imaging core facility in the Eurasian part. Here they develop multiparametric high-content imaging approaches for both, the generation and visualization of reactive oxygen species along with other crucial signaling molecules.